223 related articles for article (PubMed ID: 36195892)
1. Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.
Rubio-Perez J; Rodríguez-Perez ÁR; Díaz-Blázquez M; Moreno-García V; Dómine-Gómez M
J Med Case Rep; 2022 Oct; 16(1):365. PubMed ID: 36195892
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
3. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
4. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
[TBL] [Abstract][Full Text] [Related]
6. A Case Report of Hemophagocytic Lymphohistiocytosis and Meningitis Due to Atezolizumab Treatment for Lung Adenocarcinoma.
Ota H; Munechika M; Tobino K; Uchida K; Muarakami Y
Cureus; 2024 Apr; 16(4):e58253. PubMed ID: 38745801
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis.
Machlańska A; Helbig G; Chromik K; Zapała M; Zwiernik B; Selmaj K
Mult Scler; 2021 Oct; 27(11):1803-1805. PubMed ID: 33666121
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
Hagiwara S; Tanizaki J; Hayashi H; Komeda Y; Nishida N; Yoshida A; Yamamoto T; Matsubara T; Kudo M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1960. PubMed ID: 38196303
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.
Heynemann S; Vanguru V; Adelstein S; Kao S
Asia Pac J Clin Oncol; 2024 Apr; 20(2):315-318. PubMed ID: 36562695
[TBL] [Abstract][Full Text] [Related]
10. Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases.
Xu Z; Li H; Yu X; Luo J; Zhang Z
Hematology; 2024 Dec; 29(1):2340144. PubMed ID: 38606818
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy.
Rajapakse P; Andanamala H
World J Oncol; 2022 Apr; 13(2):49-52. PubMed ID: 35571340
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
Wang C; Sun W; Li Z; Wu T; Fang W
Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine-induced hemophagocytic lymphohistiocytosis with Takotsubo cardiomyopathy: a case report.
Zhou JY; Martinez JA; Shen JP
J Med Case Rep; 2019 Nov; 13(1):345. PubMed ID: 31767022
[TBL] [Abstract][Full Text] [Related]
14. [CME: Acquired Hemophagocytic Lymphohistiocytosis].
Leinenkugel G; Buser L; Vallelian F; Herfs G
Praxis (Bern 1994); 2018 Aug; 107(16):873-881. PubMed ID: 30086677
[TBL] [Abstract][Full Text] [Related]
15. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
Noseda R; Bertoli R; Müller L; Ceschi A
J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine-Induced Hemophagocytic Lymphohistiocytosis with DRESS.
Wang H; Peng J; Zeng W; Pan X
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345991
[TBL] [Abstract][Full Text] [Related]
17. Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review.
Mendes FR; Sobral KM; Culler HF; Couto SCF; Pereira J; Rocha V; Martinez GA; Lage LAPC
Medicine (Baltimore); 2020 Sep; 99(39):e22299. PubMed ID: 32991435
[TBL] [Abstract][Full Text] [Related]
18. Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.
Dupré A; Michot JM; Schoeffler A; Frumholtz L; Baroudjian B; Delyon J; Lebbe C; Lambotte O
Br J Haematol; 2020 Jun; 189(5):985-992. PubMed ID: 32243578
[No Abstract] [Full Text] [Related]
19. PD-1 blockader-associated atypical hemophagocytic lymphohistiocytosis: A cautionary case report.
He L; Zhuang Y; Zhang D; Tang Z
Transfus Apher Sci; 2023 Apr; 62(2):103603. PubMed ID: 36470726
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
Liu LL; Skribek M; Harmenberg U; Gerling M
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]